RaySearch Laboratories AB (27R) Financial Statements
RaySearch Laboratories AB Financial Overview
RaySearch Laboratories AB's market cap is currently $631.42M. The company's EPS TTM is $6.21; its P/E ratio is 32.66; and it has a dividend yield of 1.62%. RaySearch Laboratories AB is estimated to report earnings on November 3, 2026, and the estimated EPS forecast is $0.22. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.34B | $ 1.19B | $ 1.02B | $ 843.65M | $ 641.67M |
| Gross Profit | $ 951.40M | $ 1.09B | $ 915.58M | $ 748.66M | $ 591.28M |
| Operating Income | $ 321.80M | $ 260.49M | $ 114.88M | $ 42.74M | $ -52.64M |
| EBITDA | $ 612.80M | $ 571.25M | $ 405.94M | $ 340.85M | $ 197.36M |
| Net Income | $ 227.80M | $ 203.51M | $ 81.57M | $ 23.78M | $ -47.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 407.30M | $ 462.74M | $ 343.68M | $ 160.27M | $ 102.53M |
| Total Assets | $ 1.99B | $ 2.09B | $ 1.95B | $ 1.88B | $ 1.74B |
| Total Debt | $ 394.80M | $ 471.93M | $ 529.36M | $ 555.39M | $ 561.40M |
| Net Debt | $ -12.50M | $ 9.19M | $ 185.68M | $ 395.12M | $ 458.86M |
| Total Liabilities | $ 1.01B | $ 1.21B | $ 1.22B | $ 1.22B | $ 1.09B |
| Stockholders' Equity | $ 985.30M | $ 876.71M | $ 735.23M | $ 657.16M | $ 628.31M |
| Cash Flow | |||||
| Free Cash Flow | $ 358.90M | $ 267.69M | $ 246.60M | $ 125.28M | $ -17.06M |
| Operating Cash Flow | $ 387.00M | $ 485.23M | $ 455.93M | $ 356.78M | $ 238.16M |
| Investing Cash Flow | $ -228.10M | $ -217.54M | $ -209.33M | $ -231.50M | $ -237.63M |
| Financing Cash Flow | $ -179.60M | $ -159.78M | $ -56.35M | $ -72.49M | $ -72.23M |
Currency in SEK